Blog Post

Building the Future of Pharmaceutical Manufacturing: A Phased Approach to Dark Factories

Why Invest in a Dark Factory? Pharmaceutical manufacturers are under increasing pressure to meet growing patient demand, accelerate drug development timelines, and adapt to evolving...

Read More
Blog Post

Human Factors in Pharma Manufacturing: Beyond Error Prevention 

Introduction: Why Human Error is a Failing Root Cause  Pharmaceutical manufacturing operates in highly regulated, high-stakes environments where deviations can impact product quality, patient safety,...

Read More
Blog Post

Empowering Operational Readiness: How Advanced Technologies Reshape Industry Practices

Operational readiness is a critical milestone for any organization embarking on new projects or processes. Achieving readiness requires more than just meticulous planning; it demands...

Read More
Blog Post

A Framework for Trust: Understanding the FDA’s AI Risk-Based Credibility Assessment (Part 1 of 3) 

Nick Armstrong, Senior Director of Digital Enablement at CAI and co-chair of the ISPE Community of Practice on AI, specializes in the intersection of artificial...

Read More